Literature DB >> 26632416

Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden.

Ingrid C A W Konings1, Grace N Sidharta2, Femme Harinck1, Cora M Aalfs3, Jan-Werner Poley1, Jacobien M Kieffer2, Marianne A Kuenen2, Ellen M A Smets4, Anja Wagner5, Jeanin E van Hooft6, Anja van Rens7, Paul Fockens6, Marco J Bruno1, Eveline M A Bleiker2,7.   

Abstract

BACKGROUND: When assessing the feasibility of surveillance for pancreatic cancer (PC), it is important to address its psychological burden. The aim of this ongoing study is to evaluate the psychological burden of annual pancreatic surveillance for individuals at high risk to develop PC.
METHODS: This is a multicenter prospective study. High-risk individuals who undergo annual pancreatic surveillance with magnetic resonance imaging (MRI) and endoscopic ultrasound (EUS) were invited to complete questionnaires to assess motivations for participating in surveillance, experiences with participation, perceived PC risk, topics of concern, and psychological distress. Questionnaires were sent after intake for participation (T1), after the first MRI and EUS (T2), and after the MRI and EUS 1 (T3), 2 (T4), and 3 years (T5) after first surveillance.
RESULTS: In total, 140 out of 152 individuals returned one or more of the questionnaires (response 92%); 477 questionnaires were analyzed. The most frequently reported motivation for participating in surveillance was the possible early detection of (a precursor stage of) cancer (95-100%). Only a minority of respondents experienced MRI and EUS as uncomfortable (10% and 11%, respectively), and respondents dreaded their next EUS investigation less as surveillance progressed. Respondents' cancer worries decreased significantly over time, and both their anxiety and depression scores remained stable and low over the 3-year period of follow-up.
CONCLUSIONS: The psychological burden of pancreatic surveillance is low at all assessments. Therefore, from a psychological point of view, participation of high-risk individuals in an annual pancreatic surveillance program is feasible.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26632416     DOI: 10.1002/pon.4047

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  14 in total

1.  Relationship between individual and family characteristics and psychosocial factors in persons with familial pancreatic cancer.

Authors:  Meghan Underhill; Fangxin Hong; Janette Lawrence; Traci Blonquist; Sapna Syngal
Journal:  Psychooncology       Date:  2018-04-19       Impact factor: 3.894

Review 2.  Surveillance for neoplasia in the pancreas.

Authors:  Kasper A Overbeek; Djuna L Cahen; Marcia Irene Canto; Marco J Bruno
Journal:  Best Pract Res Clin Gastroenterol       Date:  2016-11-05       Impact factor: 3.043

Review 3.  Advances in Hereditary Colorectal and Pancreatic Cancers.

Authors:  Meghan L Underhill; Katharine A Germansky; Matthew B Yurgelun
Journal:  Clin Ther       Date:  2016-04-02       Impact factor: 3.393

4.  Long-term positive psychological outcomes in an Australian pancreatic cancer screening program.

Authors:  R S O'Neill; B Meiser; S Emmanuel; D B Williams; A Stoita
Journal:  Fam Cancer       Date:  2020-01       Impact factor: 2.375

5.  Clinical Data Prediction Model to Identify Patients With Early-Stage Pancreatic Cancer.

Authors:  Qinyu Chen; Daniel R Cherry; Vinit Nalawade; Edmund M Qiao; Abhishek Kumar; Andrew M Lowy; Daniel R Simpson; James D Murphy
Journal:  JCO Clin Cancer Inform       Date:  2021-03

6.  The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.

Authors:  Ashley Crook; Rebekah Kwa; Sarah Ephraums; Mathilda Wilding; Lavvina Thiyagarajan; Jane Fleming; Katrina Moore; Yemima Berman
Journal:  Fam Cancer       Date:  2021-05-08       Impact factor: 2.446

Review 7.  Familial pancreatic cancer: Concept, management and issues.

Authors:  Hiroyuki Matsubayashi; Kyoichi Takaori; Chigusa Morizane; Hiroyuki Maguchi; Masamichi Mizuma; Hideaki Takahashi; Keita Wada; Hiroko Hosoi; Shinichi Yachida; Masami Suzuki; Risa Usui; Toru Furukawa; Junji Furuse; Takamitsu Sato; Makoto Ueno; Yoshimi Kiyozumi; Susumu Hijioka; Nobumasa Mizuno; Takeshi Terashima; Masaki Mizumoto; Yuzo Kodama; Masako Torishima; Takahisa Kawaguchi; Reiko Ashida; Masayuki Kitano; Keiji Hanada; Masayuki Furukawa; Ken Kawabe; Yoshiyuki Majima; Toru Shimosegawa
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

8.  German National Case Collection for familial pancreatic Cancer (FaPaCa) - acceptance and psychological aspects of a pancreatic cancer screening program.

Authors:  Frederike S Franke; Elvira Matthäi; Emily P Slater; Christoph Schicker; Johannes Kruse; Detlef K Bartsch
Journal:  Hered Cancer Clin Pract       Date:  2018-11-29       Impact factor: 2.857

9.  Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance.

Authors:  Ingrid C A W Konings; Femme Harinck; Marianne A Kuenen; Grace N Sidharta; Jacobien M Kieffer; Cora M Aalfs; Jan-Werner Poley; Ellen M A Smets; Anja Wagner; Anja van Rens; Frank P Vleggaar; Margreet G E M Ausems; Paul Fockens; Jeanin E van Hooft; Marco J Bruno; Eveline M A Bleiker
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

Review 10.  Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review.

Authors:  Irina Mihaela Cazacu; Adriana Alexandra Luzuriaga Chavez; Adrian Saftoiu; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2019 Jan-Feb       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.